Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Thermo Fisher Scientific Expands ImmunoCAP Test Availability Across U.S.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sutter Health and Allina Health Sign...

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to...

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following...

US-based medical device company Artivion has completed its acquisition...

Thermo Fisher Scientific, the world leader in serving science announced it is making ImmunoCAP™ Specific IgE tests available to more patients across the U.S. The ImmunoCAP tests are now available to patients at all Kroger Health The Little Clinic LLC (“The Little Clinic”) locations, through a blood draw taken on site.

The ImmunoCAP specific IgE regional respiratory profiles now offered at The Little Clinic® require one blood draw that is analyzed at an offsite clinical laboratory. These tests are not new to the industry and are backed by 50+ years of research and development. This expansion into The Little Clinic sites will help enable more patients to take actionable preventative health steps to mitigate their allergies.

The Asthma and Allergy Foundation of America estimates that more than 100 million Americans experience various types of allergies each year, with allergies being the sixth leading cause of chronic illness in the U.S.¹ Identifying potential allergic triggers is an important component of managing patients presenting with upper and lower respiratory symptoms.

Discovering the actual cause of allergy-like symptoms is vital to empowering patients to address their condition from a preventative medicine standpoint, allowing a more personalized management plan,” said Gary Falcetano, PA-C, AE-C, scientific affairs manager, Thermo Fisher Scientific. “Adding trusted and accurate ImmunoCAP testing to all The Little Clinic locations will enable clinicians to help many more patients get the answers they need to proactively manage their health.”

The Little Clinic’s onsite licensed health care professionals provide credible and convenient care to patients in a neighborhood grocery store. These clinicians can deliver personalized care through a variety of convenient, low-cost treatment, screening, and diagnostic services. Offering the ImmunoCAP blood test in local communities is one more service that makes healthcare accessible and convenient to patients.

Documented in more than 4,000 peer-reviewed publications and referenced in health guidelines around the globe, ImmunoCAP blood tests can help identify allergic sensitization to common environmental allergens – seasonal and perennial, indoor and outdoor.

ImmunoCAP specific IgE tests are the gold standard in in-vitro allergy diagnostics with hundreds of whole allergen, allergen mixes, and allergen component tests, which can be performed irrespective of a patient’s age, skin condition, medication, disease activity, and pregnancy.²ˉ⁴

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Sutter Health and Allina Health Sign Definitive Agreement to Join Forces

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to Build the Largest Pan-Asian Healthcare Investment Platform

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to Transform Healthcare

The National Health Service is moving forward with plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »